Physician

Mehdi A Khan, DO

According to 2025 Medicare claims, Mehdi Khan, DO (NPI: 1679569214) practices ophthalmology in the Buffalo-Cheektowaga, NY market, with the plurality of this provider's patient population coming from Erie, NY. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF LONG ISLAND (NPI: 1285675660; TIN: 112498332) and primary practice location at 14221-5974.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 644 traditional Medicare patients, billed 5,776 HCPCS/CPT codes, and received $620,995 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 2,005 prescription claims across 787 beneficiaries totaling $51,295 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 16 records totaling $705. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $330,902 to $620,995. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $27,871 to $51,295. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$310K$621K2015 Medicare payment: $330,902 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $357,880 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $401,116 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $402,723 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $412,495 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $400,927 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $491,829 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $477,448 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $514,665 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $620,995 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156274,954$330,902
20166754,871$357,880
20176864,512$401,116
20186584,824$402,723
20196934,872$412,495
20206254,855$400,927
20217024,657$491,829
20226784,277$477,448
20235924,029$514,665
20246445,776$620,995

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$39K$79K2015 Drug cost: $27,871 (USD; Tot_Drug_Cst)2016 Drug cost: $27,532 (USD; Tot_Drug_Cst)2017 Drug cost: $26,744 (USD; Tot_Drug_Cst)2018 Drug cost: $30,275 (USD; Tot_Drug_Cst)2019 Drug cost: $51,433 (USD; Tot_Drug_Cst)2020 Drug cost: $73,147 (USD; Tot_Drug_Cst)2021 Drug cost: $77,939 (USD; Tot_Drug_Cst)2022 Drug cost: $78,983 (USD; Tot_Drug_Cst)2023 Drug cost: $66,963 (USD; Tot_Drug_Cst)2024 Drug cost: $51,295 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015295631$27,871
2016280612$27,532
2017345820$26,744
2018419945$30,275
20194991,251$51,433
20208011,970$73,147
20218672,155$77,939
20221,0232,557$78,983
20239392,313$66,963
20247872,005$51,295

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye153558$93
92014Established patient complete exam of visual system535828$85
J9035Injection, bevacizumab, 10 mg104349$57
92134Imaging of retina533984$30
92250Photography of the retina8890$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2348,861$11,292
Brimonidine TartrateBrimonidine Tartrate702,994$7,660
MoxifloxacinMoxifloxacin Hcl2854,252$5,020
Ciprofloxacin HclCiprofloxacin Hcl3738,247$4,632
TobramycinTobramycin50210,894$3,617

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$705Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mehdi A. Khan, DO?

Tedicare shows public-source Medicare data for Mehdi A. Khan, DO (NPI 1679569214), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mehdi A. Khan, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mehdi A. Khan, DO?

Mehdi A. Khan, DO is linked to OPHTHALMIC CONSULTANTS OF LONG ISLAND (billing NPI 1285675660) in the available physician profile data.

Does Mehdi A. Khan, DO have Open Payments data?

Mehdi A. Khan, DO has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.